Prostate cancer
Conditions
Interventions
Index test:PSMA PET-CT/US fusion targeted biopsy tissue pathology,MRI/US fusion targeted biopsy tissue pathology,PSMA systematic biopsy tissue pathology
Sponsors
The First Affiliated Hospital of Soochow University
Eligibility
Sex/Gender
Male
Age
40 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1) Male; 2) Patients who are suspected of prostate cancer due to increased PSA, positive rectal examination or imaging indications, and are planning to undergo prostate biopsy for definitive diagnosis; 3) Patients who voluntarily participate in this trial after being informed of the existing treatment plan;
Exclusion criteria
Exclusion criteria: 1) PSA>100ng/ml; 2) Those suffering from other serious systemic diseases, which researchers believe may interfere with the treatment, evaluation and compliance of this trial, including severe respiratory, circulatory, neurological, mental, digestive, endocrine, immune, urinary and other system diseases; or other patients who are assessed before anesthesia and are unable to tolerate general anesthesia surgery; 3) Patients who are participating in other clinical trials, or have participated in other clinical trials and have not ended for less than a year; 4) Patients who researchers judge are not suitable to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| detection rate of prostate cancer;detection rate of clinically significant prostate cancer;sensitivity;specificity; | — |
Countries
China
Contacts
Public ContactHuang Yuhua
The First Affiliated Hospital of Soochow University
Outcome results
None listed